NORMAL SITUATION

PHARMATWORK

Financial year 2022 · closed on 31/12/2022
Net result
-7,5 k €
+60.8% YoY
Gross margin
49,3 k €
+872.7% YoY
Equity
-10,3 k €
-260.0% YoY
Workforce
1,0 ETP
+400.0% YoY

Company — Normal situation.

What does PHARMATWORK do?

PHARMATWORK is a company registered in Belgium. It employs on average 1,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0728.708.045
Legal form
Private limited company
Contributed capital
5 000,00 €
Latest accounts
31/12/2022
Average workforce
1,0 ETP
Joint committees (1)
  • 2000
Signals
Good liquidityHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20222021
Income statement
Gross margin49,3 k €-6,4 k €
EBITDA-14 €-14 k €
Operating result-4,3 k €-18,3 k €
Net result-7,5 k €-19 k €
Balance sheet
Equity-10,3 k €-2,9 k €
Total assets146,5 k €181,6 k €
Cash48,6 k €114,2 k €
Debts152,5 k €183,4 k €
Other
Workforce1,0 ETP0,2 ETP
Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active · 1 ended

Active mandates

Liesbeth DEJONGHE

Director · since 20 juin 2019

Active

Ended mandates

Axel Dejonghe

Director · since 20 juin 2019

Ended
Annual accounts

Full financial information

2022202120202019
Type of accountAbridged modelAbridged modelAbridged modelMicro model
Start of the financial year01/01/202201/01/202101/01/202020/06/2019
Closing of the financial year31/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months7 months
Filing date14/07/202312/07/202214/07/202128/07/2020
General meeting17/06/202317/06/202217/06/202130/06/2020
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

4 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202217/06/202314/07/2023DutchPDF
Abridged model31/12/202117/06/202212/07/2022DutchPDF
Abridged model31/12/202017/06/202114/07/2021DutchPDF
Micro model31/12/201930/06/202028/07/2020DutchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2022 · 1 active · 1 ended

Active mandates

Liesbeth DEJONGHE

Director · since 20 juin 2019

Active

Ended mandates

Axel Dejonghe

Director · since 20 juin 2019

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2022
    Annual accounts 2022-7,5 k €
  2. 2021
    Annual accounts 2021-19 k €